Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 5 | 0 | 0 | 5 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
acid sphingomyelinase | 2 | 0 | 0 | 2 |
thioredoxin reductase | 16 | 0 | 0 | 16 |
USP1 protein, partial | 15 | 0 | 0 | 15 |
TDP1 protein | 24 | 0 | 0 | 24 |
vitamin D3 receptor isoform VDRA | 8 | 0 | 0 | 8 |
importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
flap endonuclease 1 | 6 | 0 | 0 | 6 |
serine/threonine-protein kinase PLK1 | 4 | 0 | 0 | 4 |
snurportin-1 | 3 | 0 | 0 | 3 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 13 | 0 | 0 | 13 |
urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
plasminogen precursor | 4 | 0 | 0 | 4 |
urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
geminin | 27 | 0 | 0 | 27 |
DNA polymerase kappa isoform 1 | 5 | 0 | 0 | 5 |
fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Transthyretin | 0 | 0 | 1 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 1 | 2 |
Fatty acid-binding protein, adipocyte | 0 | 1 | 1 | 2 |
Cyclin-A2 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 1 | 3 |
Cyclin-dependent kinase 2 | 0 | 1 | 1 | 2 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 4 | 0 | 0 | 4 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 18 | 0 | 0 | 18 |
5-hydroxytryptamine receptor 2C | 0 | 13 | 3 | 16 |
5-hydroxytryptamine receptor 2A | 0 | 11 | 4 | 16 |
5-hydroxytryptamine receptor 1A | 0 | 15 | 5 | 22 |
5-hydroxytryptamine receptor 1B | 0 | 12 | 2 | 15 |
5-hydroxytryptamine receptor 1D | 0 | 8 | 3 | 12 |
5-hydroxytryptamine receptor 1F | 0 | 7 | 2 | 10 |
5-hydroxytryptamine receptor 2B | 0 | 10 | 3 | 13 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 2 | 4 |
Sodium-dependent serotonin transporter | 0 | 12 | 1 | 13 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 4 | 2 | 6 |
5-hydroxytryptamine receptor 5A | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 5B | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 3A | 0 | 7 | 2 | 9 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 2 | 7 |
5-hydroxytryptamine receptor 3B | 0 | 7 | 2 | 9 |
phosphopantetheinyl transferase | 13 | 0 | 0 | 13 |
euchromatic histone-lysine N-methyltransferase 2 | 28 | 0 | 0 | 28 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 3 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 3 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 10 | 3 | 1 | 14 |
Cytochrome P450 3A4 | 0 | 6 | 0 | 7 |
5-hydroxytryptamine receptor 1A | 0 | 7 | 3 | 11 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 3 | 0 | 4 |
Cytochrome P450 2C9 | 0 | 7 | 0 | 7 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 3 | 0 | 4 |
D(2) dopamine receptor | 0 | 12 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit beta-1 | 10 | 3 | 1 | 14 |
Alpha-1B adrenergic receptor | 0 | 12 | 2 | 14 |
Translocator protein | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 10 | 3 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 10 | 3 | 1 | 14 |
D | 0 | 4 | 0 | 4 |
D(3) dopamine receptor | 0 | 3 | 0 | 3 |
Alpha-2B adrenergic receptor | 0 | 8 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 10 | 3 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 10 | 3 | 1 | 14 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 8 | 1 | 10 |
Alpha-2A adrenergic receptor | 0 | 8 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 10 | 3 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 10 | 3 | 1 | 14 |
Alpha-1D adrenergic receptor | 0 | 12 | 2 | 15 |
Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
Alpha-1D adrenergic receptor | 0 | 14 | 2 | 19 |
5-hydroxytryptamine receptor 1D | 0 | 6 | 1 | 9 |
5-hydroxytryptamine receptor 1B | 0 | 4 | 2 | 6 |
5-hydroxytryptamine receptor 2C | 0 | 17 | 0 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 10 | 3 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 10 | 3 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 10 | 3 | 1 | 14 |
5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
Alpha-1A adrenergic receptor | 0 | 7 | 3 | 15 |
Alpha-1B adrenergic receptor | 0 | 6 | 3 | 12 |
Alpha-1A adrenergic receptor | 0 | 14 | 3 | 17 |
5-hydroxytryptamine receptor 5A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 7 | 0 | 8 | 0 | 8 |
D(2) dopamine receptor | 0 | 11 | 1 | 12 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 10 | 4 | 1 | 15 |
Gamma-aminobutyric acid receptor subunit beta-3 | 10 | 3 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit beta-2 | 10 | 3 | 1 | 14 |
D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
GABA theta subunit | 10 | 3 | 1 | 14 |
Sigma non-opioid intracellular receptor 1 | 0 | 10 | 1 | 11 |
Gamma-aminobutyric acid receptor subunit epsilon | 10 | 3 | 1 | 14 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 12 | 0 | 0 | 12 |
estrogen nuclear receptor alpha | 31 | 0 | 0 | 31 |
Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase Lck | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase Fyn | 0 | 1 | 1 | 2 |
Fibrinogen C domain-containing protein 1 | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
NFKB1 protein, partial | 6 | 0 | 0 | 6 |
GLS protein | 13 | 0 | 0 | 13 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 19 | 0 | 0 | 19 |
cytochrome P450 2D6 | 14 | 0 | 0 | 14 |
arylsulfatase A | 9 | 0 | 0 | 9 |
cytochrome P450 2D6 isoform 1 | 8 | 0 | 0 | 8 |
D(1A) dopamine receptor | 8 | 0 | 0 | 8 |
chromobox protein homolog 1 | 22 | 0 | 0 | 22 |
atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 4 | 0 | 0 | 4 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 15 | 0 | 0 | 15 |
muscarinic acetylcholine receptor M1 | 14 | 0 | 0 | 14 |
Solute carrier family 22 member 1 | 0 | 11 | 0 | 16 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 7 | 0 | 0 | 7 |
ATP-binding cassette sub-family C member 3 | 0 | 19 | 0 | 19 |
Multidrug resistance-associated protein 4 | 0 | 20 | 0 | 20 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 13 | 1 | 14 |
Bile salt export pump | 0 | 27 | 0 | 28 |
Albumin | 0 | 0 | 2 | 2 |
High affinity nerve growth factor receptor | 0 | 1 | 2 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 8 | 0 | 8 |
Muscarinic acetylcholine receptor M2 | 0 | 10 | 3 | 17 |
Muscarinic acetylcholine receptor M4 | 0 | 10 | 3 | 16 |
Muscarinic acetylcholine receptor M1 | 0 | 5 | 2 | 11 |
Muscarinic acetylcholine receptor M3 | 0 | 5 | 2 | 10 |
Muscarinic acetylcholine receptor M4 | 0 | 5 | 1 | 9 |
Muscarinic acetylcholine receptor M5 | 0 | 5 | 1 | 9 |
Muscarinic acetylcholine receptor M5 | 0 | 10 | 3 | 16 |
Alpha-2A adrenergic receptor | 0 | 15 | 2 | 18 |
Muscarinic acetylcholine receptor M2 | 0 | 6 | 1 | 11 |
Muscarinic acetylcholine receptor M1 | 0 | 10 | 3 | 17 |
Angiotensin-converting enzyme | 0 | 4 | 0 | 4 |
Alpha-2B adrenergic receptor | 0 | 15 | 2 | 18 |
Alpha-2C adrenergic receptor | 0 | 9 | 2 | 12 |
Muscarinic acetylcholine receptor M3 | 0 | 10 | 3 | 16 |
D(1A) dopamine receptor | 0 | 5 | 0 | 6 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 8 | 1 | 9 |
Histamine H2 receptor | 0 | 7 | 2 | 9 |
5-hydroxytryptamine receptor 2A | 0 | 14 | 0 | 14 |
Histamine H1 receptor | 0 | 4 | 1 | 5 |
Histamine H1 receptor | 0 | 8 | 2 | 10 |
D(3) dopamine receptor | 0 | 11 | 0 | 11 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 14 | 0 | 14 |
Histamine H2 receptor | 9 | 2 | 1 | 15 |
D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 2 | 0 | 2 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 1 | 3 |
Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 11 | 0 | 11 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 1 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 1 | 4 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 2 | 4 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 4 | 0 | 4 |
Canalicular multispecific organic anion transporter 1 | 0 | 17 | 0 | 17 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Ataxin-2 | 9 | 0 | 0 | 9 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 2 | 2 | 4 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
ATAD5 protein, partial | 8 | 0 | 0 | 8 |
Microtubule-associated protein tau | 10 | 0 | 0 | 10 |
estrogen-related nuclear receptor alpha | 21 | 0 | 0 | 21 |
Bloom syndrome protein isoform 1 | 9 | 0 | 0 | 9 |
lamin isoform A-delta10 | 26 | 0 | 0 | 26 |
neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 14 | 0 | 0 | 14 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
thyroid stimulating hormone receptor | 13 | 0 | 0 | 13 |
alpha-galactosidase | 3 | 0 | 0 | 3 |
cytochrome P450 2C19 precursor | 5 | 0 | 0 | 5 |
lethal factor (plasmid) | 9 | 0 | 0 | 9 |
Nitric oxide synthase, endothelial | 0 | 3 | 0 | 5 |
Nitric oxide synthase, brain | 0 | 3 | 0 | 4 |
Nitric oxide synthase, brain | 0 | 2 | 0 | 4 |
Nitric oxide synthase, inducible | 0 | 3 | 0 | 4 |
Nitric oxide synthase, inducible | 0 | 3 | 1 | 7 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
acetylcholinesterase | 12 | 0 | 0 | 12 |
RAR-related orphan receptor gamma | 18 | 0 | 0 | 18 |
GLI family zinc finger 3 | 20 | 0 | 0 | 20 |
AR protein | 26 | 0 | 0 | 26 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 13 | 0 | 0 | 13 |
retinoic acid nuclear receptor alpha variant 1 | 16 | 0 | 0 | 16 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 14 | 0 | 0 | 14 |
IDH1 | 10 | 0 | 0 | 10 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform 2 | 16 | 0 | 0 | 16 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 2 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 2 |
Urease | 0 | 2 | 0 | 2 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Spike glycoprotein | 14 | 0 | 1 | 15 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 9 | 0 | 0 | 9 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 11 | 0 | 0 | 11 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 3 | 0 | 0 | 3 |
hypothetical protein, conserved | 2 | 0 | 0 | 2 |
EWS/FLI fusion protein | 13 | 0 | 0 | 13 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
peroxisome proliferator-activated receptor delta | 9 | 0 | 0 | 9 |
Rac1 protein | 0 | 0 | 1 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 8 | 0 | 9 |
Carbonic anhydrase 2 | 0 | 8 | 0 | 10 |
Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
Integrin beta-3 | 4 | 1 | 0 | 5 |
Myeloperoxidase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 4 | 1 | 0 | 5 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Adenosine receptor A1 | 0 | 1 | 0 | 2 |
Adenosine receptor A2a | 0 | 1 | 1 | 3 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
regulator of G-protein signaling 4 | 10 | 0 | 0 | 10 |
Beta-1 adrenergic receptor | 0 | 0 | 2 | 2 |
Beta-2 adrenergic receptor | 0 | 4 | 2 | 6 |
Beta-1 adrenergic receptor | 0 | 4 | 2 | 6 |
Beta-3 adrenergic receptor | 0 | 0 | 2 | 2 |
TAR DNA-binding protein 43 | 5 | 0 | 0 | 5 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 11 | 0 | 0 | 11 |
retinoid X nuclear receptor alpha | 10 | 0 | 0 | 10 |
pregnane X nuclear receptor | 12 | 0 | 0 | 12 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 4 | 1 | 5 |
glp-1 receptor, partial | 6 | 0 | 0 | 6 |
G | 6 | 0 | 0 | 6 |
aryl hydrocarbon receptor | 12 | 0 | 0 | 12 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 11 | 0 | 0 | 11 |
thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
nuclear receptor ROR-gamma isoform 1 | 8 | 0 | 0 | 8 |
cytochrome P450 3A4 isoform 1 | 10 | 0 | 0 | 10 |
Voltage-dependent calcium channel gamma-2 subunit | 8 | 0 | 0 | 8 |
Interferon beta | 9 | 0 | 0 | 9 |
HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
Glutamate receptor 2 | 8 | 2 | 1 | 11 |
Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
Chain A, Cruzipain | 3 | 0 | 0 | 3 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Inositol monophosphatase 1 | 7 | 0 | 0 | 7 |
Solute carrier organic anion transporter family member 1B3 | 0 | 3 | 0 | 5 |
Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 11 | 0 | 0 | 11 |
Angiotensin-converting enzyme | 0 | 0 | 0 | 1 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
B2 bradykinin receptor | 0 | 2 | 1 | 5 |
B1 bradykinin receptor | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
Thrombopoietin | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 8 | 0 | 0 | 8 |
M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Chain A, Beta-lactamase | 10 | 0 | 0 | 10 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 4 | 0 | 6 | 0 | 7 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 5A, mitochondrial | 0 | 5 | 0 | 6 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 9 | 0 | 5 | 0 | 6 |
Carbonic anhydrase 15 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 4 |
15-lipoxygenase, partial | 5 | 0 | 0 | 5 |
estrogen receptor 2 (ER beta) | 8 | 0 | 0 | 8 |
progesterone receptor | 9 | 0 | 0 | 9 |
67.9K protein | 3 | 0 | 0 | 3 |
peroxisome proliferator activated receptor gamma | 11 | 0 | 0 | 11 |
peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
survival motor neuron protein isoform d | 6 | 0 | 0 | 6 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 3 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 5 | 0 | 5 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
Corticotropin-releasing factor receptor 2 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 4 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 0 | 1 | 1 |
GALC protein | 6 | 0 | 0 | 6 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 11 | 0 | 0 | 11 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 3 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 3 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 2 | 0 | 2 |
farnesoid X nuclear receptor | 6 | 0 | 0 | 6 |
activating transcription factor 6 | 5 | 0 | 0 | 5 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
streptokinase A precursor | 0 | 0 | 3 | 3 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 2 | 1 | 3 |
30S ribosomal protein S7 | 0 | 2 | 1 | 3 |
50S ribosomal protein L15 | 0 | 2 | 1 | 3 |
Cellular tumor antigen p53 | 17 | 0 | 0 | 17 |
50S ribosomal protein L10 | 0 | 2 | 1 | 3 |
50S ribosomal protein L11 | 0 | 2 | 1 | 3 |
50S ribosomal protein L7/L12 | 0 | 2 | 1 | 3 |
50S ribosomal protein L19 | 0 | 2 | 1 | 3 |
50S ribosomal protein L1 | 0 | 2 | 1 | 3 |
50S ribosomal protein L20 | 0 | 2 | 1 | 3 |
50S ribosomal protein L27 | 0 | 2 | 1 | 3 |
50S ribosomal protein L28 | 0 | 2 | 1 | 3 |
50S ribosomal protein L29 | 0 | 2 | 1 | 3 |
50S ribosomal protein L31 | 0 | 2 | 1 | 3 |
50S ribosomal protein L31 type B | 0 | 2 | 1 | 3 |
50S ribosomal protein L32 | 0 | 2 | 1 | 3 |
50S ribosomal protein L33 | 0 | 2 | 1 | 3 |
50S ribosomal protein L34 | 0 | 2 | 1 | 3 |
50S ribosomal protein L35 | 0 | 2 | 1 | 3 |
50S ribosomal protein L36 | 0 | 2 | 1 | 3 |
30S ribosomal protein S10 | 0 | 2 | 1 | 3 |
30S ribosomal protein S11 | 0 | 2 | 1 | 3 |
30S ribosomal protein S12 | 0 | 2 | 1 | 3 |
30S ribosomal protein S13 | 0 | 2 | 1 | 3 |
30S ribosomal protein S16 | 0 | 2 | 1 | 3 |
30S ribosomal protein S18 | 0 | 2 | 1 | 3 |
30S ribosomal protein S19 | 0 | 2 | 1 | 3 |
30S ribosomal protein S20 | 0 | 2 | 1 | 3 |
30S ribosomal protein S2 | 0 | 2 | 1 | 3 |
30S ribosomal protein S3 | 0 | 2 | 1 | 3 |
30S ribosomal protein S4 | 0 | 2 | 1 | 3 |
30S ribosomal protein S5 | 0 | 2 | 1 | 3 |
30S ribosomal protein S8 | 0 | 2 | 1 | 3 |
30S ribosomal protein S9 | 0 | 2 | 1 | 3 |
50S ribosomal protein L13 | 0 | 2 | 1 | 3 |
50S ribosomal protein L14 | 0 | 2 | 1 | 3 |
50S ribosomal protein L16 | 0 | 2 | 1 | 3 |
50S ribosomal protein L23 | 0 | 2 | 1 | 3 |
30S ribosomal protein S15 | 0 | 2 | 1 | 3 |
50S ribosomal protein L17 | 0 | 2 | 1 | 3 |
50S ribosomal protein L21 | 0 | 2 | 1 | 3 |
50S ribosomal protein L30 | 0 | 2 | 1 | 3 |
50S ribosomal protein L6 | 0 | 2 | 1 | 3 |
30S ribosomal protein S14 | 0 | 2 | 1 | 3 |
30S ribosomal protein S17 | 0 | 2 | 1 | 3 |
30S ribosomal protein S1 | 0 | 2 | 1 | 3 |
50S ribosomal protein L18 | 0 | 2 | 1 | 3 |
50S ribosomal protein L2 | 0 | 2 | 1 | 3 |
50S ribosomal protein L3 | 0 | 2 | 1 | 3 |
50S ribosomal protein L24 | 0 | 2 | 1 | 3 |
50S ribosomal protein L4 | 0 | 2 | 1 | 3 |
50S ribosomal protein L22 | 0 | 2 | 1 | 3 |
50S ribosomal protein L5 | 0 | 2 | 1 | 3 |
30S ribosomal protein S21 | 0 | 2 | 1 | 3 |
50S ribosomal protein L25 | 0 | 2 | 1 | 3 |
50S ribosomal protein L36 2 | 0 | 2 | 1 | 3 |
Methionine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | 0 | 0 | 1 | 1 |
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Choline-binding protein | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 4 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Choline O-acetyltransferase | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 5 |
High affinity choline transporter 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 4 |
ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 5 |
Fumarate hydratase | 6 | 0 | 0 | 6 |
PPM1D protein | 2 | 0 | 0 | 2 |
caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
polyprotein | 6 | 0 | 0 | 6 |
caspase-3 | 3 | 0 | 0 | 3 |
Histone H2A.x | 7 | 0 | 0 | 7 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
cellular tumor antigen p53 isoform a | 5 | 0 | 0 | 5 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 5 | 0 | 0 | 5 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Procathepsin L | 0 | 0 | 1 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Cytochrome P450 2D6 | 0 | 5 | 0 | 6 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
Trypanothione reductase | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 0 | 1 | 1 |
Envelope glycoprotein | 0 | 0 | 1 | 1 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 7 | 0 | 0 | 7 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 6 | 0 | 0 | 6 |
Alpha-1B adrenergic receptor | 0 | 0 | 2 | 2 |
cytochrome P450 2C9 precursor | 4 | 0 | 0 | 4 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 3 | 0 | 4 | 0 | 5 |
Alpha-1A adrenergic receptor | 0 | 2 | 2 | 4 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 4 |
D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 3 |
Adenosine receptor A2b | 0 | 0 | 1 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 3 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Nischarin | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 6 | 0 | 6 |
Nischarin | 0 | 1 | 0 | 1 |
Luciferase | 9 | 0 | 0 | 9 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase EHMT1 | 0 | 1 | 0 | 1 |
apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
Lysine-specific demethylase 4A | 0 | 1 | 0 | 1 |
Hypoxia-inducible factor 1-alpha | 0 | 0 | 1 | 1 |
Methylcytosine dioxygenase TET2 | 0 | 1 | 0 | 1 |
Deoxyhypusine hydroxylase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 0 | 3 |
Sodium channel protein type 1 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 1 | 7 |
Cytochrome P450 2J2 | 0 | 4 | 0 | 4 |
Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 5 | 1 | 7 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 5 | 1 | 7 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 5 | 1 | 7 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 5 | 1 | 7 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 5 | 1 | 7 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 5 | 1 | 7 |
Hsf1 protein | 0 | 0 | 1 | 1 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
Protein cereblon | 0 | 2 | 0 | 2 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
dopamine D1 receptor | 3 | 0 | 0 | 3 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 3 | 0 | 0 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
Serine/threonine-protein kinase Chk1 | 0 | 1 | 0 | 1 |
G-protein coupled receptor 35 | 0 | 0 | 1 | 1 |
Motilin receptor | 0 | 0 | 1 | 1 |
low molecular weight phosphotyrosine protein phosphatase isoform c | 0 | 1 | 0 | 1 |
Motilin receptor | 0 | 1 | 1 | 2 |
Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
Albumin | 0 | 1 | 1 | 2 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Chitinase B | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
Glucagon-like peptide 1 receptor | 0 | 0 | 1 | 1 |
Glucagon-like peptide 1 receptor | 0 | 1 | 1 | 2 |
Glucagon receptor | 0 | 0 | 1 | 1 |
Glucagon receptor | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 0 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 5 | 0 | 0 | 5 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 3 | 3 | 6 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 3 | 0 | 0 | 3 |
Chain A, Glutamate receptor 2 | 0 | 0 | 1 | 1 |
Chain A, Glutamate receptor 2 | 0 | 0 | 1 | 1 |
Chain C, Glutamate receptor 2 | 0 | 0 | 1 | 1 |
endonuclease IV | 3 | 0 | 0 | 3 |
Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
Glutamate receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor 3 | 0 | 2 | 1 | 3 |
Glutamate receptor 4 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 1 | 0 | 3 | 1 | 4 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 2 | 4 |
Glutamate receptor 1 | 0 | 1 | 1 | 2 |
Glutamate receptor 2 | 0 | 1 | 1 | 2 |
Glutamate receptor 3 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
Glutamate receptor 4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 3 | 2 | 5 |
Substance-K receptor | 0 | 0 | 0 | 1 |
E-selectin | 0 | 0 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 1 | 2 |
Delta-type opioid receptor | 0 | 1 | 1 | 2 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
T cell receptor, partial | 1 | 0 | 0 | 1 |
luteinizing hormone receptor | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
TSHR protein | 1 | 0 | 0 | 1 |
Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
Smad3 | 3 | 0 | 0 | 3 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
luciferase | 1 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
pyruvate kinase PKM isoform a | 2 | 0 | 0 | 2 |
caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
Vpr | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
Cruzipain | 0 | 1 | 0 | 1 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 3E | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 2 | 4 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3D | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3C | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
perilipin-5 | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 3 |
Atrial natriuretic peptide receptor 1 | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 2 | 0 | 2 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Nitric oxide synthase, endothelial | 0 | 3 | 0 | 3 |
Collagenase 3 | 0 | 1 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
prostaglandin E2 receptor EP2 subtype | 0 | 0 | 0 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 2 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
ClpP | 1 | 0 | 0 | 1 |
Mcl-1 | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
Bifunctional cytochrome P450/NADPH--P450 reductase | 0 | 0 | 1 | 1 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
Bombesin receptor subtype-3 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Fatty acid synthase | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 2 | 0 | 0 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
WD repeat-containing protein 5 | 0 | 1 | 0 | 1 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase 2A | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Cytosolic endo-beta-N-acetylglucosaminidase | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 2 |
Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 2 | 2 | 4 |
Vasopressin V1a receptor | 0 | 1 | 0 | 1 |
Vasopressin V1a receptor | 0 | 2 | 1 | 3 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 4 | 0 | 4 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 2 | 3 |
Gastrin/cholecystokinin type B receptor | 0 | 3 | 3 | 6 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 1E | 0 | 2 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 3 | 1 | 4 |
Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Beta-casein | 0 | 1 | 0 | 1 |
Interstitial collagenase | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-mannosidase 2C1 | 0 | 0 | 1 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Bromodomain-containing protein 2 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Glucocorticoid receptor | 0 | 2 | 1 | 8 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Androgen receptor | 0 | 1 | 0 | 1 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 3 | 0 | 3 |
Chain A, PUTRESCINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN | 0 | 1 | 0 | 1 |
Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN | 0 | 1 | 0 | 1 |
Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN | 0 | 1 | 0 | 1 |
Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 1 | 1 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
S-adenosylmethionine decarboxylase proenzyme | 0 | 0 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
Diacylglycerol kinase alpha | 0 | 1 | 0 | 1 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 1 | 2 |
Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carboxypeptidase M | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
guanine nucleotide-binding protein subunit alpha-15 | 0 | 1 | 1 | 2 |
D(3) dopamine receptor isoform e | 1 | 0 | 0 | 1 |
trace amine-associated receptor 1 | 0 | 1 | 1 | 2 |
Phenylethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
Dopamine beta-hydroxylase | 0 | 0 | 0 | 1 |
Beta-secretase 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
RAF proto-oncogene serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
Malate dehydrogenase | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
Chymotrypsinogen B | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
Dual specificity mitogen-activated protein kinase kinase 2 | 0 | 1 | 0 | 1 |
Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 1 | 0 | 1 |
MAP kinase-activated protein kinase 5 | 0 | 1 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |